These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 35602)

  • 1. Effect of dopaminergic agonists and antagonists on in vivo cyclic nucleotide content: relation of guanosine 3':5'- monophosphate (cGMP) changes in cerebellum to behavior.
    Breese GR; Mueller RA; Mailman RB
    J Pharmacol Exp Ther; 1979 May; 209(2):262-70. PubMed ID: 35602
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of dopaminergic agonists and antagonists on cerebellar guanosine-3',5'-monophosphate (cGMP).
    Breese GR; Mailman RB; Ondrusek MG; Harden TK; Mueller RA
    Life Sci; 1978 Aug; 23(5):533-6. PubMed ID: 29192
    [No Abstract]   [Full Text] [Related]  

  • 3. Striato-cerebellar pathway controlling cyclic GMP content in the cerebellum: role of dopamine, GABA and enkephalins.
    Biggio G; Corda MG; Casu M; Gessa GL
    Adv Biochem Psychopharmacol; 1978; 18():227-44. PubMed ID: 206110
    [No Abstract]   [Full Text] [Related]  

  • 4. Depression of some drug-induced in vivo changes of cerebellar guanosine 3',5'-monophosphate by control of motor and respiratory responses.
    Lundberg DB; Breese GR; Mailman RB; Frye GD; Mueller RA
    Mol Pharmacol; 1979 Mar; 15(2):246-56. PubMed ID: 38389
    [No Abstract]   [Full Text] [Related]  

  • 5. Cyclic nucleotide levels in the rat striatum and cerebellum--in vivo effects of dopamine and acetylcholine receptor agonists and antagonists.
    Puri SK; Choma P; Volicer L
    Biochem Pharmacol; 1978; 27(19):2333-6. PubMed ID: 215154
    [No Abstract]   [Full Text] [Related]  

  • 6. Dopaminergic supersensitivity in the striatum.
    Ungerstedt U; Ljungberg T; Hoffer B; Siggins G
    Adv Neurol; 1975; 9():57-65. PubMed ID: 167568
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacologically induced changes in the 3':5'-cyclic guanosine monophosphate content of rat cerebellar cortex: difference between apomorphine, haloperidol and harmaline.
    Biggio G; Costa E; Guidotti A
    J Pharmacol Exp Ther; 1977 Jan; 200(1):207-15. PubMed ID: 13199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes of rat cerebellar guanosine 3',5'-cyclic phosphate by dopaminergic mechanisms in vivo.
    Burkard WP; Pieri L; Haefely W
    Adv Biochem Psychopharmacol; 1976; 15():315-24. PubMed ID: 192051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential sensitivity to morphine-induced analgesia and motor activity in two inbred strains of mice: behavioral and biochemical correlations.
    Racagni G; Bruno F; Iuliano E; Paoletti R
    J Pharmacol Exp Ther; 1979 Apr; 209(1):111-6. PubMed ID: 219179
    [No Abstract]   [Full Text] [Related]  

  • 10. Actions of dopaminergic agonists on cyclic AMP production in rat brain homogenates.
    Iversen LL; Horn AS; Miller RJ
    Adv Neurol; 1975; 9():197-212. PubMed ID: 167565
    [No Abstract]   [Full Text] [Related]  

  • 11. Evidence for multiple dopamine receptors involved in the modulation of acetylcholine release in the striatum.
    Hársing LG; Vizi ES
    Pol J Pharmacol Pharm; 1985; 37(3):383-96. PubMed ID: 2866504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of the striatum-enriched phosphodiesterase PDE10A: a novel approach to the treatment of psychosis.
    Siuciak JA; Chapin DS; Harms JF; Lebel LA; McCarthy SA; Chambers L; Shrikhande A; Wong S; Menniti FS; Schmidt CJ
    Neuropharmacology; 2006 Aug; 51(2):386-96. PubMed ID: 16780899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of chronic treatment with neuroleptics on the content of 3',5'-cyclic guanosine monophosphate in cerebellar cortex of rats.
    Biggio G; Corda MG; Casu M; Gessa GL
    Life Sci; 1978 Aug; 23(6):649-52. PubMed ID: 29201
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of ethanol on cyclic nucleotides in vivo: consequences of controlling motor and respiratory changes.
    Breese GR; Lundberg DB; Mailman RB; Frye GD; Mueller RA
    Drug Alcohol Depend; 1979; 4(3-4):321-6. PubMed ID: 230951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kainic acid-induced lesion of dopaminergic target cells in the striatum: consequences on the dynamics of cerebellar cGMP.
    Biggio G; Corda MG; Casu M; Gessa GL
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Aug; 304(1):5-7. PubMed ID: 211448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of dopaminephilic agents and cAMP on tyrosine hydroxylase activity.
    Goldstein M; Bronaugh RL; Lew JU; Ohashi T; Drummond GS; Fuxe K
    Adv Biochem Psychopharmacol; 1977; 16():447-53. PubMed ID: 18892
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug-induced dopaminergic supersensitivity.
    Moore KE; Thornburg JE
    Adv Neurol; 1975; 9():93-104. PubMed ID: 1146661
    [No Abstract]   [Full Text] [Related]  

  • 18. A critical assessment of behavioural test procedures used to analyse dopaminergic and antidopaminergic drugs.
    Nohria V
    Methods Find Exp Clin Pharmacol; 1983; 5(6):357-64. PubMed ID: 6137599
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of dopaminergic agonists and antagonists of feeding in intact and 6-hydroxydopamine-treated rats.
    Heffner TG; Zigmond MJ; Stricker EM
    J Pharmacol Exp Ther; 1977 May; 201(2):386-99. PubMed ID: 859104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sedative action of low doses of dopaminergic agents.
    Maj J; Przewlocka B; Kukulka L
    Pol J Pharmacol Pharm; 1977; 29(1):11-21. PubMed ID: 857245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.